Novilytic
PrivateLast Round
Early Funding
Dec 15, 2025
Total Funding Raised
$5.99M
Company Overview
Novilytic is a biotechnology and nanotechnology company that has developed a platform to monitor the quality of lifesaving medicines in biopharmaceutical manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Quality Management
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novilytic Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Novilytic Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Dec 15, 2025 | ||||
| Grant | Nov 19, 2025 | ||||
| Accelerator | Jun 24, 2025 | ||||
| Seed | May 3, 2022 | ||||
| Early Funding | Apr 13, 2021 | ||||
Grant | Jul 16, 2020 |
Key People
Founding team and executive leadership
Novilytic Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purdue Research Foundation | Seed |
| Elevate Ventures | Seed |
| NIH RADx | Grant |
| Purdue Innovates Ventures | Seed |
| Purdue Foundry | Seed |
| BioTools Innovator | Grant, Accelerator |
| National Institute of General Medical Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2020
$1.4M grant from the National Institute of General Medical Sciences and NIH RADx.
Novilytic Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novilytic's valuation, stock price, and market status.